Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Protocols


EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.


Title Abstract Investigator
Pancreatic Reference Set Application: Ivan Blasutig-University of Toronto (2014) The primary objective of this study is to independently validate a panel of serum biomarkers for the early detection of pancreatic ductal adenocarcinoma ... Blasutig, Ivan
Pancreatic Reference Set Application: Kazufumi Honda-National Cancer Center (2014) Among human malignancies, invasive ductal adenocarcinoma of the pancreas has the worst prognosis,with a 5-year survival rate of less than 10%. Most patients ... Honda, Kazufumi
Pancreatic Reference Set Application: Michael Hollingsworth-University of Nebraska (2014) Hollingsworth, Michael
Pancreatic Reference Set Application: Surinder Batra- University of Nebraska (2014) To explore the diagnostic significance of the most differentially overexpressed secretory mucin MUC4 and MUC5AC for early detection Batra, Surinder
Phase II Validation of a New Panel of Biomarkers for Early Detection of Ovarian Cancer While all cancer patients could potentially benefit from earlier detection and prevention, the development of new screening technologies and chemoprevention ... Mor, Gil
Polyp Prediction Study Meltzer, Stephen
Pre-Validation of Metabolomic Biomarkers of Prostate Cancer Chinnaiyan, Arul M.
Pre-operative plevic mass study Cramer, Daniel
Preliminary Clinical Characterization of Serum Biomarkers for Colorectal Neoplasms Brenner, Dean
Preliminary Validation of Biomarkers for the Detection of Colorectal Adenomas (Team Project #1) the goal of identifying those biomarkers developed by the GI collaborative that will predict the presence of advanced colorectal adenomas. Brenner, Dean
Presence of simian virus 40 DNA sequences in human Gazdar, Adi
Prognostic Markers in Lynch Syndrome Colorectal Cancers Lynch, Henry
Prostate Active Surveillance Study Primary Objective: To discover and confirm biomarkers that predict aggressive disease as defined by pre-specified histological, PSA, clinical criteria, or ... Lin UW, Daniel W.
Prostate Rapid Pre-Validation Set Determine which markers move to validation using the prospectie prostate reference set samples. Sanda, Martin
Prostate Rapid Reference Set Application: Brian Haab - Van Andel (2006) To evaluate TSP-1 as a marker to specifically detect prostate cancer Haab, Brian
Prostate Rapid Reference Set Application: Daniel Chan/Patty Beckman- JHU/University of Minnesota (2007) see publication Chan, Daniel
Prostate Rapid Reference Set Application: Eleftherios Diamandis - Mt Sinai (2006) Diamandis, Eleftherios P.
Prostate Rapid Reference Set Application: Robert Getzenberg - John Hopkins (2006) Analyze marker EPCA2 on 123 observations (60 prostate cancers and 63 non-prostate cancers) Getzenberg, Robert H.
Prostate Reference Set Application: William Isaacs-John Hopkins (2010) Can SNP genotyping assist in the prediction of biopsy results for prostate cancer. Isaacs, William
Prostate Reference Set Application: proPSA-Dan Chan-JHU (2008) see Publication Chan, Daniel
Prostate Upgrading Team Project Aim 1: We will develop a risk assessment tool using commonly-collected clinical information from a series of contemporary radical prostatectomies to predict ... Thompson, Ian M.
Prostate-Specific Glycoproteins for Early Detection of Prostate Cancer Zhang, Hui L.
Protein profiling for detection of high risk breast cancer Semmes, John
Proteomic Approach for Diagnostic Applications in Head and Neck Cancer To evaluate the test characteristics of a panel of biomarkers for identifying patients with early stage head and neck squamous cell carcinoma (HNSCC). The ... Tainsky, Michael A.
Proteomic Data Resources for EDRN Ovary Cancer Researchers within the EDRN This project will generate a highly valuable data resource and make it available to all EDRN ovarian cancer researchers. The resource will include ... McIntosh, Martin
Proteomic Genetic and Longitudinal Pathways to Ovarian Cancer Biomarkers Discovery and verification of early detection ovarian cancer plasma/serum biomarkers. Skates, Steven
Proteomic Profiling of Serum and Other Body Fluids for the Early Detection of Colon Cancers Semmes, John
Proteomics Biomarker Development Laboratory The Biomarker Development Laboratory is focused on the application of a proteomic approach for the development of cancer biomarkers. The laboratory will apply ... Not listed
Protocol for Comparing Promoter Hypermethylation Methods in NSCLC Tockman, Melvyn S.
Release of Set Aside Funds - microRNA Biomarkers for Renal Cell Carcinoma Thompson, Ian M.
2015 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take place January 20–21, 2016 in Bethesda, Maryland.

Announcement 08/26/2015

Thank you to everyone who made the 29th EDRN Steering Committee Meeting a success. The orientation for new and continuing EDRN PIs will be held Wednesday-Thursday, January 20-21, 2016, on the NCI campus. More information will be available later this summer.

Announcement 06/30/2015

A funding opportunity for a new pancreatic cancer initiative, called The Pancreatic Cancer Detection Consortium (U01), has been released. For more information, please go to /grants/guide/ pa-files/ PAR-15-289.html.